用抑郁症解读阿尔茨海默病:分子洞察力和治疗目标
Zekun Li1, Hongmin Guo1, Yihao Ge1
1Department of Rehabilitation Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, P. R. China.
Journal of cellular and molecular medicine
|March 12, 2025
概括
研究人员确定了两个关键基因,ITGB5和SPCS1,作为抑郁症阿尔茨海默病 (AD) 的预测生物标志物. 这些发现为这种复杂的并发症提供了潜在的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 和抑郁症经常同时发生,影响患者的预后.
- 确定共享的生物机制和生物标志物对于有效的治疗策略至关重要.
研究的目的:
- 为了确定与抑郁症同时发生的阿尔茨海默病 (AD) 的预测生物标志物.
- 探索潜在的治疗目标来管理AD与抑郁症.
主要方法:
- 门德尔随机化 (MR) 分析以确认AD-抑郁相关性.
- 权重基因同表达网络分析 (WGCNA) 以确定与疾病相关的基因.
- 使用Degree和MCC算法,再加上机器学习的生物信息查,以确定共享的基因.
- 用于生物标志物验证的诺摩图分析.
主要成果:
- 证实了AD和抑郁症之间的正相关性.
- 确定了1569个与阿尔茨海默病相关的基因和1629个与抑郁症相关的基因;84个基因是两者共同的.
- ITGB5和SPCS1被验证为AD与抑郁症 (AUC>0.7) 的预测生物标志物.
- 确定了四种针对ITGB5的药物.
结论:
- ITGB5和SPCS1作为有希望的预测生物标志物用于诊断AD与抑郁症.
- 这些基因代表了阿尔茨海默病和同时出现的抑郁症的潜在治疗点.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
933
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
414
相关概念视频
Alzheimer's Disease: Overview
409
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
409
Alzheimer's Disease: Treatment
141
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
141
Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Human Genetics
510
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
510
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
